- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg med 2019 nCoV, PD-1
I alt 135 resultater
-
Leidos Life SciencesUnited States Department of DefenseTrukket tilbageCOVID-19 | Covid19 | Coronavirussygdom 2019 | SARS-CoV-2 infektion | SARS-CoV-2 akut luftvejssygdom | Covid-19-pandemi | COVID-19 virusinfektion | COVID-19 virus sygdom | 2019 Ny Coronavirus-sygdom | 2019 Ny Coronavirus-infektion | 2019-nCoV sygdom | 2019-nCoV-infektion
-
Leidos Life SciencesUnited States Department of DefenseAktiv, ikke rekrutterendeCOVID-19 | Covid19 | Coronavirussygdom 2019 | SARS-CoV-2 infektion | SARS-CoV-2 akut luftvejssygdom | Covid-19-pandemi | COVID-19 virusinfektion | COVID-19 virus sygdom | 2019 Ny Coronavirus-sygdom | 2019 Ny Coronavirus-infektion | 2019-nCoV sygdom | 2019-nCoV-infektionForenede Stater
-
Guohui LiRekrutteringPD-1 | Immunrelaterede bivirkningerKina
-
Merck Sharp & Dohme LLCRekrutteringIkke-småcellet lungekræft | Faste tumorer | Programmeret celledød-1 (PD1, PD-1) | Programmeret celledød 1 Ligand 1 (PDL1, PD-L1) | Programmeret celledød 1 ligand 2 (PDL2, PD-L2)Japan
-
Leidos Life SciencesUnited States Department of DefenseAfsluttetCOVID-19 | Covid19 | Coronavirussygdom 2019 | SARS-CoV2-infektion | SARS-CoV-2 akut luftvejssygdom | Covid-19-pandemi | COVID-19 virusinfektion | COVID-19 virus sygdom | 2019 Ny Coronavirus-sygdom | 2019 Ny Coronavirus-infektion | 2019-nCoV sygdom | 2019-nCoV-infektionForenede Stater
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research Institute; Center for...SuspenderetCOVID-19 | Coronavirusinfektion | SARS-CoV-2 | 2019-nCoV | 2019 ny coronavirusForenede Stater
-
Ningbo Cancer HospitalUkendtAvancerede maligniteter | PD-1 antistof | CAR-T cellerKina
-
Shanghai International Medical CenterUkendtAvanceret solid tumor | PD-1 antistof | CAR-T cellerKina
-
Beijing Children's HospitalThe First Affiliated Hospital of Anhui Medical University; Shengjing Hospital og andre samarbejdspartnereUkendt
-
University Hospital, MontpellierAfsluttetPatienter, der modtager anti-PD-1 eller Anti-PD-L1 immunterapierFrankrig
-
Peking UniversityIkke rekrutterer endnuGastroøsofageal Junction Cancer | Kemoradioterapi | PD-1
-
Agenus Inc.AfsluttetAvancerede solide kræftformer | Advanced Solid Cancers Refractory to PD-1Forenede Stater
-
Beijing Friendship HospitalIkke rekrutterer endnu
-
Sun Yat-sen UniversityRekrutteringPD-1 inhibitor | G-CSFKina
-
AudibleHealth AI, Inc.Sunrise Research Institute; Analytical Solutions Group, Inc.; Kelley Medical... og andre samarbejdspartnereAfsluttetCoronavirussygdom 2019 | SARS-CoV-2 infektion | Covid-19-pandemi | COVID-19 virusinfektion | Coronavirus sygdom-19 | COVID-19 virus sygdom | 2019 Ny Coronavirus-sygdom | 2019 Ny Coronavirus-infektion | 2019-nCoV sygdomForenede Stater
-
Tongji HospitalUkendt
-
Peking Union Medical College HospitalTongji HospitalUkendt
-
Dr Gerry Gin Wai KwokThe University of Hong KongUkendtCOVID-19 | Lungebetændelse, viral | SARS-CoV-2 | 2019-nCoV
-
Jieming QUAfsluttet
-
Tongji HospitalUkendt
-
Sinovac Life Sciences Co., Ltd.RekrutteringInfektion i de øvre luftveje forårsaget af 2019-nCoVKina
-
University of PecsAfsluttetCOVID-19 | SARS-CoV-2 | Coronavirus | 2019-nCoV | 2019-nCoVUngarn
-
Chongqing Medical UniversityTrukket tilbage
-
Tongji HospitalUkendt
-
Tongji HospitalUkendt2019-nCoV Alvorlig lungebetændelseKina
-
Shandong New Time Pharmaceutical Co., LTDIkke rekrutterer endnu
-
Baodong QinUkendtKemoterapi effekt | Immunterapi | Tumormutationsbyrde | PD-1/L1-hæmmerKina
-
Icahn School of Medicine at Mount SinaiRekrutteringKræft | Skjoldbruskkirtel | PD-1Forenede Stater
-
Xijing HospitalRekrutteringPD-1 | Lokalt avanceret gastrisk adenocarcinomKina
-
Wuhan Union Hospital, ChinaRekrutteringGastroøsofageal Junction Cancer | PD-1 | Neoadjuverende kemoradioterapiKina
-
First Affiliated Hospital of Zhejiang UniversityAscletis Pharmaceuticals Co., Ltd.Afsluttet
-
Wuhan Union Hospital, ChinaUkendt2019-nCoV | Immunoglobulin fra helbredte patienterKina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI)RekrutteringRefraktær MSI - H faste tumorer forud for PD-(L) 1-terapi | MSI-H tumorerForenede Stater
-
Beijing Friendship HospitalIkke rekrutterer endnu
-
Sun Yat-sen UniversityRekrutteringPD-1 inhibitor | Granulocytkoloni-stimulerende faktorKina
-
Ascletis Pharmaceuticals Co., Ltd.RekrutteringHIV-infektioner | HIV-1-infektion | PD-L1 genmutationKina
-
Sichuan Cancer Hospital and Research InstituteIkke rekrutterer endnuIntrahepatisk cholangiocarcinom | Apatinib | PD-1 antistof | Transarteriel kemoemboliseringKina
-
Shanghai Zhongshan HospitalAktiv, ikke rekrutterendeGaldevejskræft | PD-1 antistof | Lenvatinib | GemoxKina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRekruttering
-
Beijing Friendship HospitalAfsluttetGaldevejskræft | Capecitabin | Målrettet molekylær terapi | Anti-PD-1 terapiKina
-
China Medical University, ChinaIkke rekrutterer endnuPD-1 antistof | Gastrointestinale tumorer | DC-celle | NK-celle
-
Second Affiliated Hospital of Wenzhou Medical UniversityWanbangde Pharmaceutical Group Co., LTDUkendtLungebetændelse på grund af ny coronavirus | 2019-nCoVKina
-
Institut National de la Santé Et de la Recherche...SuspenderetCoronavirusFrankrig, Fransk Guyana
-
University Hospital HeidelbergDepartment of Dermatology, Heidelberg University HospitalAfsluttetMelanom | Dyrke motion | PD-1 antistofferTyskland
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Affiliated Cancer Hospital... og andre samarbejdspartnereRekrutteringStrålebehandling | HNSCC | PD-1Kina
-
Chinese PLA General HospitalRekrutteringHodgkin lymfom | Anti-PD-1 antistof resistentKina
-
Sun Yat-sen UniversityRekrutteringImmunterapi | DMMR tyktarmskræft | Anti PD-1Kina
-
Fudan UniversityIkke rekrutterer endnuMavekræft | MSI-H | Adjuverende terapi | PD-1 immunterapiKina
-
RenJi HospitalRekrutteringUrothelial carcinom blære | PD-1 inhibitorKina